Allarity Therapeutics, Inc. cotiza a 0.86 USD y tiene una capitalización bursátil de $14M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the personalized treatment of cancer using drug-specific companion diagnostics ge…
| Periodo | 2026-05 | 2026-03 | 2025-11 | 2025-08 |
|---|---|---|---|---|
| Real | $-0.17 | $-0.21 | $-0.19 | $-0.15 |
| Estimado | $-0.22 | $-0.22 | $-0.23 | $-0.21 |
| Sorpresa | +22.7% | +4.5% | +17.4% | +28.6% |
| Métrica | ALLR | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -3939.1% | -38.6% | -3900.4% |
| Net Margin | -3509.7% | -33.6% | -3476.1% |
| FCF Margin | -4633.8% | -13.9% | -4619.9% |
| ROE | -114.3% | -40.4% | -73.9% |
| ROA | -61.5% | -32.0% | -29.5% |
| Current Ratio | 2.13 | 2.84 | -0.71 |
| Debt / Equity | — | 0.28 | — |